SCHEMBL2816485

SCHEMBL2816485

CCOC(=O)C(C)(CNC(=O)c1cnc2ccccn12)c1ccc(NC(=O)c2ccc(OC)c(OC)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KIT P10721 2/20 0.41
DDR2 Q16832 2/20 0.41
DDR1 Q08345 1/20 0.41
NPC1 O15118 3/20 0.41
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 2/20 0.40
NAMPT P43490 1/20 0.40
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NQO2 P16083 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554528 0.88 MEN1 (0.47) MAPTALDH1A1MEN1KMT2AKIT
SCHEMBL4440155 0.83 MEN1 (0.46) MAPTALDH1A1MEN1KMT2AKIT
SCHEMBL4554530 0.80 MEN1 (0.48) MAPTALDH1A1MEN1KMT2AKIT
SCHEMBL4554526 0.79 MEN1 (0.49) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL2816819 0.70 MEN1 (0.63) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL2815122 0.69 KMT2A (0.57) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL2816004 0.69 MAPT (0.55) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL2814902 0.68 MAPT (0.61) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL4554813 0.67 NPC1 (0.51) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL7301440 0.67 SMN1; SMN2 (0.78) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed
EP-2134676-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE Addex Pharma SA (CH) 2009-12-23 EP disclosed
WO-2008117175-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG MAPT 4813/4885ALDH1A1 1769/4885MAPK1 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.